Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FDOPA-PET/MRI for Pre-operative Glioma Evaluation
NCT02371031Phase 1Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2015
- Primary completion
- Jul 2016
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Fluorodopa F 18 in glioma, sponsored by Washington University School of Medicine. Primary endpoint: Percentage of cases in which the addition of FDOPA-PET to MRI changes the surgical plan at 2 weeks. Started Mar 2015; status: terminated.
02
Drugs
Fluorodopa F 18
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02371031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371031.